PeproMene Bio
Irvine
About PeproMene Bio
PeproMene Bio, Inc is an Irvine, California-based clinical-stage biotech startup. We are dedicated to the development of innovative therapeutics for cancer and immunological illnesses. Our CAR-T treatment concept for BAFFR is based on a new antibody that targets the B-cell Activating Factor Receptor (BAFF-R).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.0M
- Last round: Corporate Round (Dec 2024)
- Website: pepromenebio.com
- Phone: (949) 564-4085
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/pepromene-bio-113548 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.